MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
29.63
+0.81
+2.81%
Opening 11:36 12/07 EST
OPEN
28.88
PREV CLOSE
28.82
HIGH
29.69
LOW
28.88
VOLUME
68.02K
TURNOVER
1.34M
52 WEEK HIGH
44.46
52 WEEK LOW
20.84
MARKET CAP
1.43B
P/E (TTM)
19.91
1D
5D
1M
3M
1Y
5Y
Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders have earned a 10% CAGR over the last five years
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Simply Wall St. · 2d ago
BRIEF-Amphastar Pharmaceuticals Inc Says On Nov 15, Co's Unit Entered Into A Supply Agreement With Nanjing Letop Biotechnology Co.
Reuters · 11/18 21:54
Opioid reversal agent naloxone approvable for OTC use – FDA
Seekingalpha · 11/15 18:37
Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, Executive V.P. of Corporate Administration Center, will participate in an Analyst-Moderated fireside chat at the 2022 Jefferies London Healthcare Con...
ACCESSWIRE · 11/10 21:05
Amphastar authorizes $50M buyback
Seekingalpha · 11/08 07:16
BRIEF-Amphastar Pharmaceuticals Inc Reports Net Revenues Of $120.1 Million For The Third Quarter
Reuters · 11/07 21:55
Amphastar Pharmaceuticals Non-GAAP EPS of $0.38 misses by $0.01, revenue of $120.13M misses by $6.27M
Seekingalpha · 11/07 21:32
Amphastar Pharmaceuticals Q3 Adj. EPS $0.38 Misses $0.39 Estimate, Sales $120.13M Miss $126.37M Estimate
Benzinga · 11/07 21:10
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. The Company is primarily focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (API) products. Its segments include Finished pharmaceutical products and API products. The Finished pharmaceutical products segment manufactures, markets and distributes Primatene Mist, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs, as well as certain contract manufacturing. The API segment manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development. Primatene Mist is an epinephrine inhalation product, which is indicated for the temporary relief of mild symptoms of intermittent asthma. Glucagon for injection emergency kit is indicated for the treatment of severe hypoglycemia.

Webull offers kinds of Amphastar Pharmaceuticals Inc stock information, including NASDAQ:AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.